I agree Novogen are concentrating their efforts on their three lead anti cancer drugs and that is what they are spending their money on.
The FSHD program which falls under the Project Jacob Hope is being funded by FSHD Global, but the scientists working on it are from Novogen, you won't see any reference to it in any Novogen financial data because they are not funding it, FSHD Global are.
